1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Mariana Agban conducted an unannounced initial complaint visit to investigate the allegation mentioned above. LPA met with Administrator Lora Pana and explained the purpose of the visit. A tour of the physical plant was conducted to ensure that client health and safety were being maintained and that the facility remained in compliance with Title 22 Regulations. LPA requested copies of the Staff Roster, Client Roster, Client#1 (C1)'s IPP, and other documents pertinent to the investigation.
Allegation: Staff did not adhere to residents IPP plan
It was reported that facility staff administered the antipsychotic medication Haloperidol 2 mg on November 2, 2025, after receiving verbal approval from C1’s parent, who does not hold medical conservatorship. Interviews with the Administrator, S2, and S3 revealed that the medication was administered in response to C1’s behavior. The Administrator confirmed that staff relied solely on the parent’s consent and did not obtain approval from the North Los Angeles County Regional Center (NLACRC).
(Continue on 9099C) |